001026458 001__ 1026458
001026458 005__ 20250701125847.0
001026458 0247_ $$2doi$$a10.1016/j.ijrobp.2023.06.308
001026458 0247_ $$2ISSN$$a0360-3016
001026458 0247_ $$2ISSN$$a1879-355X
001026458 037__ $$aFZJ-2024-03407
001026458 041__ $$aEnglish
001026458 082__ $$a610
001026458 1001_ $$0P:(DE-HGF)0$$aPetrich, C.$$b0$$eCorresponding author
001026458 1112_ $$a54. Jahrestagung der Deutschen Gesellschaft für Medizinphysik$$cMagdeburg$$d2023-09-27 - 2023-09-30$$gDGMP$$wGermany
001026458 245__ $$aTowards Clinical Translation of Microbeam Radiation Therapy (MRT) with a Compact Source
001026458 260__ $$c2023
001026458 3367_ $$0PUB:(DE-HGF)1$$2PUB:(DE-HGF)$$aAbstract$$babstract$$mabstract$$s1721117404_10763
001026458 3367_ $$033$$2EndNote$$aConference Paper
001026458 3367_ $$2BibTeX$$aINPROCEEDINGS
001026458 3367_ $$2DRIVER$$aconferenceObject
001026458 3367_ $$2DataCite$$aOutput Types/Conference Abstract
001026458 3367_ $$2ORCID$$aOTHER
001026458 520__ $$aPurpose/Objective(s)MRT is an innovative concept of spatially fractionated radiation therapy that has demonstrated substantially improved normal tissue tolerance while achieving local tumor control in a wealth of preclinical studies. In MRT a collimator shapes a few micrometers wide planar x-ray beams with a spacing of a few 100 µm. MRT has the potential to improve cancer treatment substantially. However, until now, only a few large 3rd generation synchrotrons provide beam parameters that would allow patient treatments and therefore, MRT has not yet become clinically available. For a clinical translation, compact x-ray sources are required, that produce high dose rate orthovoltage x-rays from a micrometer sized emitter.Materials/MethodsWe developed and built a first prototype of a line focus x-ray tube (LFxT) dedicated to preclinical MRT research. By exploiting the heat capacity limit, the LFxT can deliver dose rates above 100 Gy/s from a just 50 µm-wide focal spot without destroying the rapidly (>200 Hz) rotating x-ray target. A bespoke collimator splits the homogeneous x-ray field into 50 µm wide high-dose peaks separated by 350 µm wide low-dose troughs (valleys). While the prototype in our lab is restricted to a power of 90 kW and 10 Gy/s at 300 kVp, we have started the development of the first clinically usable LFxT-2 at 1.5 MW power and >100 Gy/s at 600 kVp beam quality. We investigated the clinical applicability of the LFxT-2 by performing retrospective treatment planning studies. In particular, we were examining, whether 600 kVp photons would suffice to meet clinical dose constraints in MRT treatments treatment scenarios for first clinical use of MRT. We coupled the open source platform 3D Slicer with an in-house developed dose calculation algorithm for MRT treatment planning. For comparability of spatially fractionated MRT doses with conventional broad beam treatments, the MRT dose was converted to equivalent uniform dose (EUD) and equivalent doses in 2-Gy-fractions (EQD2). The 3D Slicer RT toolkit enabled the dosimetric analysis based on dose volume histograms (DVHs).ResultsWe installed a preclinical prototype of the LFxT that is currently put into operation and commissioned. Simulations show the feasibility of the next generation LFxT-2 with more than 100 Gy/s peak dose rate. Planned MRT dose distributions with the LFxT-2 meet established radiotherapy dose constraints in many of the investigated clinical cases. However, treatment planning procedures are not yet optimal and require improvement.ConclusionIn a next step, we will build the LFxT-2 and aim for first clinical MRT trials at this source. In order to further improve calculated MRT dose distributions, we will implement inverse treatment planning techniques.
001026458 536__ $$0G:(DE-HGF)POF4-5241$$a5241 - Molecular Information Processing in Cellular Systems (POF4-524)$$cPOF4-524$$fPOF IV$$x0
001026458 536__ $$0G:(GEPRIS)416790481$$aDFG project 416790481 - Tumortherapie mit Mikrostrahlen an kompakter Strahlenquelle (416790481)$$c416790481$$x1
001026458 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
001026458 7001_ $$0P:(DE-Juel1)180572$$aDimroth, A.$$b1$$eCorresponding author
001026458 7001_ $$0P:(DE-HGF)0$$aKraus, K. M.$$b2
001026458 7001_ $$0P:(DE-Juel1)159329$$aWinter, J.$$b3$$ufzj
001026458 7001_ $$0P:(DE-HGF)0$$aMatejcek, C.$$b4
001026458 7001_ $$0P:(DE-Juel1)133642$$aButzek, M.$$b5$$ufzj
001026458 7001_ $$0P:(DE-Juel1)142196$$aNatour, G.$$b6$$ufzj
001026458 7001_ $$0P:(DE-HGF)0$$aRavichandran, M.$$b7
001026458 7001_ $$0P:(DE-HGF)0$$aZimmermann, M.$$b8
001026458 7001_ $$0P:(DE-HGF)0$$aAulenbacher, K.$$b9
001026458 7001_ $$0P:(DE-HGF)0$$aGalek, M.$$b10
001026458 7001_ $$0P:(DE-HGF)0$$aWilkens, J.$$b11
001026458 7001_ $$0P:(DE-HGF)0$$aCombs, S. E.$$b12
001026458 7001_ $$0P:(DE-HGF)0$$aBartzsch, S.$$b13
001026458 773__ $$0PERI:(DE-600)1500486-7$$a10.1016/j.ijrobp.2023.06.308$$gVol. 117, no. 2, p. S38 - S39$$x0360-3016$$y2023
001026458 8564_ $$uhttps://juser.fz-juelich.de/record/1026458/files/1-s2.0-S0360301623047429-main.pdf$$yRestricted
001026458 8564_ $$uhttps://juser.fz-juelich.de/record/1026458/files/1-s2.0-S0360301623047429-main.gif?subformat=icon$$xicon$$yRestricted
001026458 8564_ $$uhttps://juser.fz-juelich.de/record/1026458/files/1-s2.0-S0360301623047429-main.jpg?subformat=icon-1440$$xicon-1440$$yRestricted
001026458 8564_ $$uhttps://juser.fz-juelich.de/record/1026458/files/1-s2.0-S0360301623047429-main.jpg?subformat=icon-180$$xicon-180$$yRestricted
001026458 8564_ $$uhttps://juser.fz-juelich.de/record/1026458/files/1-s2.0-S0360301623047429-main.jpg?subformat=icon-640$$xicon-640$$yRestricted
001026458 909CO $$ooai:juser.fz-juelich.de:1026458$$pVDB
001026458 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)180572$$aForschungszentrum Jülich$$b1$$kFZJ
001026458 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Klinikum rechts der Isar$$b2
001026458 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)159329$$aForschungszentrum Jülich$$b3$$kFZJ
001026458 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)133642$$aForschungszentrum Jülich$$b5$$kFZJ
001026458 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)142196$$aForschungszentrum Jülich$$b6$$kFZJ
001026458 9101_ $$0I:(DE-588b)36241-4$$6P:(DE-HGF)0$$aTechnische Universität München$$b8$$kTUM
001026458 9131_ $$0G:(DE-HGF)POF4-524$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5241$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vMolecular and Cellular Information Processing$$x0
001026458 9141_ $$y2024
001026458 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2023-08-24$$wger
001026458 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-24
001026458 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-24
001026458 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-08-24
001026458 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-08-24
001026458 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-24
001026458 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-08-24
001026458 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-08-24
001026458 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-08-24
001026458 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bINT J RADIAT ONCOL : 2022$$d2023-08-24
001026458 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-24
001026458 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-08-24
001026458 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-08-24
001026458 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bINT J RADIAT ONCOL : 2022$$d2023-08-24
001026458 9201_ $$0I:(DE-Juel1)ZEA-1-20090406$$kZEA-1$$lZentralinstitut für Technologie$$x0
001026458 9201_ $$0I:(DE-Juel1)ICE-3-20101013$$kICE-3$$lTroposphäre$$x1
001026458 980__ $$aabstract
001026458 980__ $$aVDB
001026458 980__ $$aI:(DE-Juel1)ZEA-1-20090406
001026458 980__ $$aI:(DE-Juel1)ICE-3-20101013
001026458 980__ $$aUNRESTRICTED
001026458 981__ $$aI:(DE-Juel1)ITE-20250108